Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey

First published 04/09/2019

Last updated 01/04/2024

EU PAS number:

EUPAS30727

Study

Finalised

Documents

Study protocol

Initial protocol

20285_Study Protocol_V2.0_2018-10-26_Redacted

English (6.84 MB - PDF)View document

Study results

20285_EU PAS Abstract_Redacted_V1.0_2021-04-06

English (371.94 KB - PDF)View document

Study report

20285_CSR_V1.0_2020-08-21_Redacted

English (4.09 MB - PDF)View document

Other information

Secondary tabs